These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8500336)

  • 21. Dilute topical proparacaine for pain relief after photorefractive keratectomy.
    Shahinian L; Jain S; Jager RD; Lin DT; Sanislo SS; Miller JF
    Ophthalmology; 1997 Aug; 104(8):1327-32. PubMed ID: 9261322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of corneal thickness after the instillation of topical anesthetics: proparacaine versus oxybuprocaine.
    Nam SM; Lee HK; Kim EK; Seo KY
    Cornea; 2006 Jan; 25(1):51-4. PubMed ID: 16331042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical drug formulations for prolonged corneal anesthesia.
    Wang L; Shankarappa SA; Tong R; Ciolino JB; Tsui JH; Chiang HH; Kohane DS
    Cornea; 2013 Jul; 32(7):1040-5. PubMed ID: 23615270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of 0.5% proparacaine stored at room temperature.
    Stiles J; Krohne S; Rankin A; Chang M
    Vet Ophthalmol; 2001 Sep; 4(3):205-7. PubMed ID: 11722785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental use of tetrodotoxin for corneal pain after excimer laser keratectomy.
    Schwartz DM; Duncan KG; Duncan JL
    Cornea; 1998 Mar; 17(2):196-9. PubMed ID: 9520198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of topical anesthesia on evaluation of corneal sensitivity and intraocular pressure in rats and dogs.
    Kim J; Kim NS; Lee KC; Lee HB; Kim MS; Kim HS
    Vet Ophthalmol; 2013 Jan; 16(1):43-6. PubMed ID: 22519957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The systemic toxicity of equipotent proxymetacaine, oxybuprocaine, and bupivacaine during continuous intravenous infusion in rats.
    Hung CH; Liu KS; Shao DZ; Cheng KI; Chen YC; Chen YW
    Anesth Analg; 2010 Jan; 110(1):238-42. PubMed ID: 19897799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of topical application of 0.5% proparacaine on corneal culture results from 33 dogs, 12 cats, and 19 horses with spontaneously arising ulcerative keratitis.
    Edwards SG; Maggs DJ; Byrne BA; Kass PH; Lassaline ME
    Vet Ophthalmol; 2019 Jul; 22(4):415-422. PubMed ID: 30193404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo.
    Essepian JP; Rajpal R; O'Brien TP
    Cornea; 1995 Jul; 14(4):402-7. PubMed ID: 7671612
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of corneal hypesthesia on the duration of proparacaine anesthetic eyedrops.
    Weiss JS; Goren MB
    Am J Ophthalmol; 1991 Sep; 112(3):326-30. PubMed ID: 1882944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of topical anesthetic agents to human keratocytes in vivo.
    Moreira LB; Kasetsuwan N; Sanchez D; Shah SS; LaBree L; McDonnell PJ
    J Cataract Refract Surg; 1999 Jul; 25(7):975-80. PubMed ID: 10404375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effects of proparacaine on human corneal thickness.
    Herse P; Siu A
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):740-4. PubMed ID: 1488880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of topical ophthalmic application of 0.5% proparacaine hydrochloride on aerobic bacterial culture results for naturally occurring infected corneal ulcers in dogs.
    Fentiman KE; Rankin AJ; Meekins JM; Roush JK
    J Am Vet Med Assoc; 2018 Nov; 253(9):1140-1145. PubMed ID: 30311533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual acuity after topical application of proparacaine.
    Bossart PJ; Stephen RL; Herr RD; Berndt D
    Ann Emerg Med; 1997 Jan; 29(1):158-60. PubMed ID: 8998096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of proparacaine to human corneal endothelial cells in vitro.
    Wen Q; Fan T; Bai S; Sui Y
    J Toxicol Sci; 2015 Aug; 40(4):427-36. PubMed ID: 26165639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs.
    Douet JY; Michel J; Regnier A
    Am J Vet Res; 2013 Oct; 74(10):1321-6. PubMed ID: 24066916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Masked trial of topical anesthesia for retinopathy of prematurity eye examinations.
    Cogen MS; Parker JS; Sleep TE; Elsas FJ; Metz TH; McGwin G
    J AAPOS; 2011 Feb; 15(1):45-8. PubMed ID: 21397805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degree of corneal anesthesia after topical application of 0.4% oxybuprocaine ophthalmic solution in normal equids.
    Little E; Yvorchuk-St Jean K; Little W; Sithole F; St Jean G
    Can J Vet Res; 2016 Oct; 80(4):329-334. PubMed ID: 27733789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dilute proparacaine for the management of acute corneal injuries in the emergency department.
    Ball IM; Seabrook J; Desai N; Allen L; Anderson S
    CJEM; 2010 Sep; 12(5):389-96. PubMed ID: 20880433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratitis from corneal anesthetic abuse after photorefractive keratectomy.
    Kim JY; Choi YS; Lee JH
    J Cataract Refract Surg; 1997 Apr; 23(3):447-9. PubMed ID: 9159692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.